Quirante, Ginalyn .
HRN: 24-42-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2025
05/25/2025
IV
500 Mg
Q8h X 8 Doses
Sp D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes